Development of ISB 1442, a CD38 and CD47 bispecific biparatopic antibody innate cell modulator for the treatment of multiple myeloma
Grandclément, C., Estoppey, C., Dheilly, E., Panagopoulou, M., Monney, T., Dreyfus, C., Loyau, J., Labanca, V., Drake, A., De Angelis, S., Rubod, A., Frei, J., Caro, L. N., Blein, S., Martini, E., Chimen, M., Matthes, T., Kaya, Z., Edwards, C. M., Edwards, J. R., Menoret, E., Kervoelen, C., Pellat-Deceunynck, C., Moreau, P., Mbow, M. L., Srivastava, A., Dyson, M. R., Zhukovsky, E. A., Perro, M., Sammicheli, S.
Published in Nature communications (06.03.2024)
Published in Nature communications (06.03.2024)
Get full text
Journal Article
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy
Passaro, A., Mancuso, P., Gandini, S., Spitaleri, G., Labanca, V., Guerini-Rocco, E., Barberis, M., Catania, C., Del Signore, E., de Marinis, F., Bertolini, F.
Published in Clinical & translational oncology (01.04.2020)
Published in Clinical & translational oncology (01.04.2020)
Get full text
Journal Article
Correction to: Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy
Passaro, A., Mancuso, P., Gandini, S., Spitaleri, G., Labanca, V., Guerini-Rocco, E., Barberis, M., Catania, C., Del Signore, E., de Marinis, F., Bertolini, F.
Published in Clinical & translational oncology (01.04.2020)
Published in Clinical & translational oncology (01.04.2020)
Get full text
Journal Article
P871: ISB 1442, A FIRST‐IN‐CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES
Grandclement, C., Estoppey, C., Dheilly, E., Panagopoulou, M., Martini, E., Labanca, V., De Angelis, S., Frei, J., Drake, A., Rubod, A., Gudi, G., Udupa, V., Koch Olsen, J., Giovannini, R., Doucey, M. A., Feldman, E., Konto, C., Srivastava, A., Perro, M., Sammicheli, S.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
12.03 ISB 1442, a first-in-class CD38 and CD47 bispecific antibody innate cell modulator for the treatment of CD38 positive hematological malignancies
Grandclement, C, Estoppey, C, Dheilly, E, Panagopoulou, M, Martini, E, Labanca, V, De Angelis, S, Frei, J, Drake, A, Rubod, A, Gudi, G, Udupa, V, Olsen, J, Giovannini, R, Doucey, M, Feldman, E, Konto, C, Srivastava, A, Zhukovsky, E, Perro, M, Sammicheli, S
Published in Journal for immunotherapy of cancer (21.09.2022)
Published in Journal for immunotherapy of cancer (21.09.2022)
Get full text
Journal Article
Molecular Monitoring of Imatinib in Chronic Myeloid Leukemia Patients in Complete Cytogenetic Remission: Does Achievement of a Stable Major Molecular Response at any Time Point Identify a Privileged Group of Patients? A Multicenter Experience in Argentina and Uruguay
Pavlovsky, Carolina, Giere, Isabel, Moiraghi, Beatriz, Pavlovsky, Miguel A, Aranguren, Pedro Negri, García, Juan, Fernandez, Isolda, Bengió, Raquel, Milone, Jorge, Labanca, Valentin, Uriarte, Rosario, Lombardi, Virginia, Reinoso, Fernanda García, Magariños, Alicia E, Martinez, Lem, Murro, Héctor, Lastiri, Francisco, Pavlovsky, Santiago
Published in Clinical lymphoma, myeloma and leukemia (01.06.2011)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2011)
Get full text
Journal Article